ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

ACOS Studies Show Shift To Less Surgery In Breast Cancer

December 15, 1978

New Task Force For Nutrition Research Urged By NCAB Committee

February 19, 1982

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998